Perspective Therapeutics CATX
NYSE CATX
$2.29 +0.10 (+4.57%)
As of: Oct 20, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Acquisitions (2023)

Updated

Perspective Therapeutics (CATX) reported Acquisitions of $2.7 million for FY2023.

Analysis

Perspective Therapeutics (CATX) Acquisitions (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -17.24 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.21 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Perspective Therapeutics 279.31 Mn 42.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -2.70 Mn
API Access

Perspective Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=CATX&period=max&api_key=YOUR_API_KEY